George Hill
Stock Analyst at Deutsche Bank
(2.93)
# 1,367
Out of 5,169 analysts
193
Total ratings
52.59%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Maintains: Buy | $42 → $37 | $24.75 | +49.49% | 3 | Mar 12, 2026 | |
| TDOC Teladoc Health | Upgrades: Buy | $11 | $5.61 | +96.08% | 19 | Mar 10, 2026 | |
| HIMS Hims & Hers Health | Maintains: Hold | $25 → $28 | $24.98 | +12.09% | 5 | Mar 10, 2026 | |
| ELV Elevance Health | Downgrades: Hold | $332 → $320 | $295.75 | +8.20% | 3 | Dec 19, 2025 | |
| HUM Humana | Maintains: Hold | $250 → $231 | $170.77 | +35.27% | 12 | Nov 7, 2025 | |
| MCK McKesson | Maintains: Buy | $775 → $856 | $941.89 | -9.12% | 8 | Sep 24, 2025 | |
| HQY HealthEquity | Maintains: Buy | $98 → $115 | $79.40 | +44.84% | 18 | Jun 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $287.57 | +25.88% | 22 | May 14, 2025 | |
| CVS CVS Health | Maintains: Buy | $66 → $70 | $74.81 | -6.43% | 7 | Feb 14, 2025 | |
| AGL agilon health | Maintains: Hold | $4 → $2 | $0.61 | +225.73% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $398 → $394 | $263.47 | +49.54% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $119 → $124 | $216.36 | -42.69% | 12 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $1.51 | +32.45% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $1.12 | +346.43% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $34.94 | +149.00% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $143.96 | +145.21% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $209.00 | +125.36% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $2.23 | +258.74% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $168.43 | +48.43% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $100.49 | +133.85% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $153.71 | +117.29% | 5 | Feb 18, 2021 |
Waystar Holding
Mar 12, 2026
Maintains: Buy
Price Target: $42 → $37
Current: $24.75
Upside: +49.49%
Teladoc Health
Mar 10, 2026
Upgrades: Buy
Price Target: $11
Current: $5.61
Upside: +96.08%
Hims & Hers Health
Mar 10, 2026
Maintains: Hold
Price Target: $25 → $28
Current: $24.98
Upside: +12.09%
Elevance Health
Dec 19, 2025
Downgrades: Hold
Price Target: $332 → $320
Current: $295.75
Upside: +8.20%
Humana
Nov 7, 2025
Maintains: Hold
Price Target: $250 → $231
Current: $170.77
Upside: +35.27%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $941.89
Upside: -9.12%
HealthEquity
Jun 5, 2025
Maintains: Buy
Price Target: $98 → $115
Current: $79.40
Upside: +44.84%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $287.57
Upside: +25.88%
CVS Health
Feb 14, 2025
Maintains: Buy
Price Target: $66 → $70
Current: $74.81
Upside: -6.43%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $0.61
Upside: +225.73%
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $263.47
Upside: +49.54%
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $216.36
Upside: -42.69%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $1.51
Upside: +32.45%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $1.12
Upside: +346.43%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $34.94
Upside: +149.00%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $143.96
Upside: +145.21%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $209.00
Upside: +125.36%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $2.23
Upside: +258.74%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $168.43
Upside: +48.43%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $100.49
Upside: +133.85%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $153.71
Upside: +117.29%